Mallinckrodt Continues M&A Spree with US$1.325 B Therakos Acquisition
By Heather Cartwright & Smita Mishra
Pharma Deals Review: Vol 2015 Issue 9 (Table of Contents)
Published: 4 Sep-2015
DOI: 10.3833/pdr.v2015.i9.2120 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In its second drug-device deal of 2015, Mallinckrodt has agreed to acquire autologous immunotherapy developer Therakos for approximately US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS